Incidence and Predictors of Relapse After Weaning Immune Suppressive Therapy in Cardiac Sarcoidosis

Sarcoidosis is a remitting-relapsing disease with a greatly variable course.1 The prevalence of cardiac involvement is estimated to be up to 25%.2,3 It has been well established that the presence of cardiac sarcoidosis is an indication for immune suppression.4 –6 Modern therapeutic strategies typically use an extended corticosteroid taper with a goal of fully suppressing the acute inflammatory process while avoiding unnecessarily high cumulative corticosteroid exposure and associated risk of adverse events.

Source: The American Journal of Cardiology - August 8, 2023 Category: Cardiology Authors: Kelly Arps, Jayanth Doss, Kelly Geiger, Karen Flores-Rosario, Adam D. DeVore, Ravi Karra, Han W. Kim, Jonathan P. Piccini, Sean D. Pokorney, Albert Y. Sun Source Type: research